⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Arog Pharmaceuticals
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Arog Pharmaceuticals just got measured.
3/10 means Arog Pharmaceuticals is currently invisible to AI search. Most AI assistants will not cite your brand when asked about your category. Claiming and applying the fixes below is the fastest way to change that.
About Arog Pharmaceuticals
Arog Pharmaceuticals is advancing crenolanib, a potent type I pan-FLT3 inhibitor, for post-HSCT maintenance in high-risk AML patients with FLT3-ITD and NPM1 mutations. Phase III-ready.
Details
Industry: Healthcare
arogpharma.comAI Visibility Breakdown
1
Structured Data
4
Content Structure
5
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Arog Pharmaceuticals.
Source & Attribution
Scored by Engagemii on June 22, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/arogpharma
Cite this score: Engagemii (2026). "AEO Score for Arog Pharmaceuticals." Retrieved from https://engagemii.com/aeo/brands/arogpharma
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform